Compare LRMR & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRMR | CZNC |
|---|---|---|
| Founded | N/A | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 425.0M |
| IPO Year | 2014 | 2009 |
| Metric | LRMR | CZNC |
|---|---|---|
| Price | $4.33 | $23.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $16.50 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 1.3M | 28.3K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | N/A | ★ 7.64 |
| EPS | N/A | ★ 1.22 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.11 |
| Revenue Next Year | $1,816.14 | N/A |
| P/E Ratio | ★ N/A | $19.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.73 | $18.02 |
| 52 Week High | $6.42 | $24.12 |
| Indicator | LRMR | CZNC |
|---|---|---|
| Relative Strength Index (RSI) | 39.27 | 49.02 |
| Support Level | $4.21 | $19.82 |
| Resistance Level | $4.45 | $24.02 |
| Average True Range (ATR) | 0.22 | 0.40 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 14.21 | 7.21 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.